| 2026 |
Hussain, M. S., Khetan, R., Albrecht, H., Krasowska, M., & Blencowe, A. (2026). Correlation of Polymer–drug Composition with Micelle Properties, Performance, and Cytotoxicity for the Oligoelectrolyte-mediated pH-triggered Release of Hydrophobic Drugs. Polymers, 18(2), 27 pages.
DOI |
| 2026 |
Khetan, R., Rajapaksha, W., Nturubika, B. D., Gillam, T. A., Brooks, D. A., Garg, S., . . . Eldi, P. (2026). Targeting F2R/PAR1 with ligand decorated lipid nanocarriers for enhanced drug delivery into ovarian cancer cells. Frontiers in Drug Delivery, 5, 15 pages.
DOI |
| 2025 |
Muta, T., Khetan, R., Song, Y., & Garg, S. (2025). Optimising Cannabidiol Delivery: Improving Water Solubility and Permeability Through Phospholipid Complexation. International Journal of Molecular Sciences, 26(6), 28 pages.
DOI Scopus8 WoS7 Europe PMC4 |
| 2025 |
Khetan, R., Lokman, N. A., Eldi, P., Price, Z. K., Oehler, M. K., Brooks, D. A., . . . Albrecht, H. (2025). Protease-Activated Receptor F2R Is a Potential Target for New Diagnostic/Prognostic and Treatment Applications for Patients with Ovarian Cancer. International Journal of Molecular Sciences, 26(17), 8529.
DOI Scopus3 WoS3 Europe PMC3 |
| 2024 |
Abid, F., Virgo, E., Kennewell, T. L., Khetan, R., Haidari, H., Kopecki, Z., . . . Garg, S. (2024). The Acid-Buffered Engineered Gel Promotes In Vitro Cutaneous Healing and Fights Resistant Bacteria in Wounds. Pharmaceutics, 16(11), 15 pages.
DOI Scopus1 WoS1 Europe PMC1 |
| 2024 |
Rajapaksha, W., Khetan, R., Johnson, I. R. D., Blencowe, A., Garg, S., Albrecht, H., & Gillam, T. A. (2024). Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment. Frontiers in Drug Delivery, 4(1339936), 19 pages.
DOI Scopus17 WoS10 Europe PMC6 |
| 2024 |
Saddam Hussain, M., Khetan, R., Albrecht, H., Krasowska, M., & Blencowe, A. (2024). Oligoelectrolyte-mediated, pH-triggered release of hydrophobic drugs from non-responsive micelles: Influence of oligo(2-vinyl pyridine)-loading on drug-loading, release and cytotoxicity. International Journal of Pharmaceutics, 661(124368), 15 pages.
DOI Scopus7 WoS7 Europe PMC5 |
| 2024 |
Khetan, R., Eldi, P., Lokman, N. A., Ricciardelli, C., Oehler, M. K., Blencowe, A., . . . Albrecht, H. (2024). Unveiling G-protein coupled receptors as potential targets for ovarian cancer nanomedicines: from RNA sequencing data analysis to in vitro validation.. J Ovarian Res, 17(1), 156.
DOI Scopus3 WoS3 Europe PMC3 |
| 2023 |
Youssef, S. H., Kim, S., Khetan, R., Afinjuomo, F., Song, Y., & Garg, S. (2023). The development of 5-fluorouracil biodegradable implants: A comparative study of PCL/PLGA blends. Journal of Drug Delivery Science and Technology, 81(104300), 14 pages.
DOI Scopus16 WoS15 |
| 2023 |
Saddam Hussain, M., Khetan, R., Clulow, A. J., Ganesan, R., MacMillan, A., Robinson, N., . . . Blencowe, A. (2023). Teaching an Old Dog New Tricks: A Global Approach to Enhancing the Cytotoxicity of Drug-Loaded, Non-responsive Micelles Using Oligoelectrolytes. ACS Applied Materials and Interfaces, 16(8), 9736-9748.
DOI Scopus6 WoS6 Europe PMC3 |
| 2022 |
Khetan, R., Dharmayanti, C., Gillam, T. A., Kübler, E., Klingler-Hoffmann, M., Ricciardelli, C., . . . Albrecht, H. (2022). Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines. Cancers, 14(10), 1-32.
DOI Scopus14 WoS14 Europe PMC15 |
